- Report
- June 2026
- 307 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 304 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 300 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 320 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 294 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 287 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 301 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 299 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 289 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 301 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 333 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- May 2026
- 279 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- April 2026
- 291 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- April 2026
- 286 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- April 2026
- 289 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- April 2026
- 305 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- April 2026
- 309 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- March 2026
- 299 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- March 2026
- 301 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- March 2026
- 292 Pages
Global
From €2274EUR$2,500USD£1,948GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more